In trials in the United States and Mexico, the Novavax COVID-19 vaccine showed an overall efficacy of 90.4 percent, potentially adding another vaccin
Read MoreCovishield's first sample, the Indian Coronavirus Serum Institute Vaccine, left Pune earlier this morning, four days before the national COVID-19 ino
Read More